EQUITEC SPECIALISTS, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 162 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
EQUITEC SPECIALISTS, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$791,000
+888.8%
85,275
+847.5%
0.15%
+2940.0%
Q4 2020$80,000
+77.8%
9,000
+47.5%
0.01%
-50.0%
Q1 2020$45,000
+9.8%
6,100
-50.8%
0.01%
-9.1%
Q4 2019$41,000
+70.8%
12,400
+7.8%
0.01%
+83.3%
Q3 2019$24,000
+2300.0%
11,500
+3733.3%
0.01%
Q2 2019$1,0003000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Sante Capital Fund, LP 115,637$1,072,0000.44%
Defender Capital, LLC. 135,466$1,255,0000.42%
Green Alpha Advisors, LLC 62,566$580,0000.40%
Harvest Investment Services, LLC 51,239$474,0000.20%
SEVEN EIGHT CAPITAL, LP 118,270$1,096,0000.15%
Cedar Brook Financial Partners, LLC 54,500$505,0000.15%
WASATCH ADVISORS LP 3,576,706$33,156,0000.14%
Banco BTG Pactual S.A. 20,000$185,0000.12%
Keystone Financial Group 60,712$563,0000.10%
Virtus ETF Advisers LLC 25,105$233,0000.10%
View complete list of INOVIO PHARMACEUTICALS INC shareholders